NEW YORK, NY (Marketwired – Feb 25, 2014)
Hospital readmission rates for prostate removal surgeries are comparably low across all three techniques — open, laparoscopic, and robotic — according to a new Swedish study. As a leading prostate cancer treatment, radical prostatectomy has evolved significantly in the past two decades. While not all men with prostate cancer are candidates for minimally invasive surgery, most prostate removal surgeries today are performed via laparoscopic radial prostatectomy (LRP) or robotic-assisted laparoscopic prostatectomy (RALP).
In a review of more than 24,000 prostate cancer patients who underwent radical prostatectomy, 90-day readmission rates held steady around 10 percent for each of the three surgical techniques. According to David B. Samadi, MD, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, beyond the low rate of hospital readmissions, the most critical finding in this study is the benefit of undergoing prostate removal surgery at a high volume hospital.
“Low hospital readmission is critical to prostate surgery success,” said Dr. Samadi. “The fact that high-volume hospitals are able to reduce the likelihood of readmission after prostate surgery by 30 percent more than lower volume hospitals is significant. For patients, treatment success is about more than technique. It’s about optimizing recovery by choosing more experienced surgeons at high volume hospitals.”
RALP is performed to remove a cancerous prostate in its entirety and is considered a “gold standard” prostate cancer treatment. Both the availability and popularity of the procedure have increased over the past decade, according to the study. In the eleven-year study period, the use of robotic prostate surgery increased from zero to 50 percent of all prostate surgery techniques.
Dr. Samadi is one of a few uniquely trained prostate surgeons with expertise across all three radical prostatectomy techniques. Building on his foundation in open surgery and laparoscopic surgery, he is an innovator in the evolution of robotics in prostate removal. Using his own Samadi Modified Advanced Robotic Technique (SMART) surgery, Dr. Samadi has performed more than 5,600 successful RALPs to date.
With quality of life after surgery as his driving goal, Dr. Samadi delivers prostate cancer cure rates of 97 percent and exceptionally high post-surgery success rates for urinary continence and sexual potency. His minimally invasive technique allows the majority of patients to return home the day after surgery and reduces the likelihood of hospital readmission.
The report, appearing online in The Journal of Urology, also found that patients age 70 and older were 17 percent more likely to require readmission after prostate surgery than those under age 60. In addition, men with high-risk prostate cancer were 78 percent more likely to require follow-up care at the hospital.
“Robotic surgery is improving everyday,” said Dr. Samadi. “By choosing an experienced surgeon at a highly regarded hospital, patients can feel confident that they are receiving the highest quality of care available.”